| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Britthaven is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Britthaven is based in Kinston, NC. You can find more information on Britthaven at www.britthaven.com
Ameritox is the nation's leader in pain prescription monitoring. Only Ameritox offers RxGuardian, the most thorough and personalized lab report available.
ATRIO Health Plans is a Medicare Advantage (MA) plan that offers Preferred Provider Organization (PPO) options, as well as a Health Maintenance Organization (HMO) Special Needs Plans for Dual Eligibles. The health plan is supported by the trusted physicians, who care for individuals and families in the Oregon counties of Douglas, Josephine, Klamath, Marion and Polk.
Aptuit Informatics is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.